Register NOW for the FREE IMF Virtual Myeloma Community Workshop

Dr. Mikhael will be kicking off the program with introductions and welcome and then we will be covering the following topics:

• Should all high-risk smoldering patients be treated?
• Is transplant still the standard of care for all eligible patients?
• Should most patients only have maintenance therapy for 2 years?

Dr. Richter will argue "yes" for each topic above and Dr. Hansen will argue "no" for each topic. 

Additional Resources:

Download the IMF's Multiple Myeloma Informational Booklets:

Download IMF publications

What Is a Clinical Trial?

*Of note, Venetoclax has already been approved to treat acute myeloid leukemia, chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adults and is now being evaluated to treat other types of cancers, including multiple myeloma. It is part of a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors that work by blocking the action of BCL-2 (a protein in the body that regulates cell death). Trials using Venetoclax were discussed in this webinar. You can learn about these three trials at the following links:

• CANOVA Clinical Trial Fact Sheet
  clinicaltrials.gov Identifier: NCT03539744
• Phase II Relapsed or Refractory Venetoclax Trial 
  clinicaltrials.gov Identifier: NCT02899052
• Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib 
  clinicaltrials.gov Identifier: NCT03314181

Workshop Sponsors:

With Support From: Abbvie, Amgen, BMS, GSK, Johnson & Johnson, Johnson & Johnson w Legend, Karyopharm, Kite, and Pfizer

(The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)

	Cervino Study CLINICAL TRIAL FACT SHEET ClinicalTrials.gov ID: NCT06158841 HOJA INFORMATIVA DEL ENSAYO CLÍNICO ID de ClinicalTrials.gov: NCT06158841
	Kyprolis Patient Resources Kyprolis Patient Brochure
	Revlimid Treatment Overview brochure POM My Disease and Treatment (pomalyst.com) Harness your power to fight MM with ABECMA®
	www.blenrep.com Together with BLENREP Homepage | TogetherWithGSK.com
	Tecvayli® Darzalex® Talvey Patient Support Program | CARVYKTI® (ciltacabtagene autoleucel)
	KaryForward, Patient Support Program KaryForward, Patient Support Program, Espanol Patient and Caregiver Brochure Treatment Experience Guide
	ELREXFIO® (elranatamab-bcmm) Info for Patients | Safety Info Your Guide to Understanding Elrexfio ELREXFIO® (elranatamab-bcmm) Personalized Patient Support | Safety Info